Please login to the form below

Not currently logged in
Email:
Password:

Gedeon Richter

This page shows the latest Gedeon Richter news and features for those working in and with pharma, biotech and healthcare.

FDA rejects Allergan’s uterine fibroid drug over safety concerns

FDA rejects Allergan’s uterine fibroid drug over safety concerns

Allergan’s selective progesterone receptor modulator is already approved in Europe, where it is sold as Esmya (ulipristal acetate) and marketed by Hungarian pharmaceutical company Gedeon Richter.

Latest news

More from news
Approximately 8 fully matching, plus 21 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Solaris Health

    Abbvie. Aimmune. Almirall. Ascensia. BD. Bio-Medical Research. Desitin. Ferring. Flexyfoot. Gedeon Richter.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics